Skip to main content
  1. Market Insights
  2. Health
  3. OTC Pharmaceuticals

Analgesics - Haiti

Haiti
  • In Haiti, the revenue in the Analgesics market is projected to reach US$22.25m in 2024.
  • This market is expected to experience an annual growth rate of 7.09% (CAGR 2024-2029).
  • When compared globally, the United States generates the highest revenue in this market, amounting to US$7.24bn in 2024.
  • In terms of per person revenues, the figure is US$1.88 in 2024.
  • Despite the limited access to healthcare services in Haiti, the demand for analgesics in the OTC Pharmaceuticals market remains high due to the prevalence of chronic pain among the population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

In-Scope

  • Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
  • Natural and synthetic agents
  • In the form of pills, capsules, gels and ointments

Out-Of-Scope

  • Prescription medicines
  • Homeopathic remedies
  • Anesthetics
Analgesics: market data & analysis - Cover

Market Insights Report

Analgesics: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Analgesics market in Haiti has been experiencing significant growth in recent years.

    Customer preferences:
    Haitian consumers have shown a growing demand for analgesics, which can be attributed to several factors. Firstly, there has been an increase in the prevalence of chronic diseases and conditions such as arthritis and migraines, leading to a higher need for pain relief medication. Additionally, the aging population in Haiti has also contributed to the rising demand for analgesics, as older individuals are more likely to experience chronic pain. Furthermore, the increasing awareness and acceptance of analgesics as an effective solution for pain management have also influenced customer preferences in Haiti.

    Trends in the market:
    One of the key trends in the Analgesics market in Haiti is the shift towards over-the-counter (OTC) analgesics. Previously, prescription-based analgesics were more commonly used in the country. However, due to the accessibility and convenience offered by OTC analgesics, consumers are increasingly opting for these products. This trend can be attributed to the growing number of pharmacies and drugstores across Haiti, making OTC analgesics more readily available to consumers. Additionally, the affordability of OTC analgesics compared to prescription-based medications also plays a significant role in this trend.

    Local special circumstances:
    Haiti is a developing country with limited access to healthcare services in certain regions. This has led to a higher reliance on self-medication among the population, including the use of analgesics. The lack of healthcare infrastructure and resources in some areas of the country makes it difficult for individuals to seek medical attention for minor ailments and pain. As a result, analgesics have become a popular choice for self-treatment among Haitians.

    Underlying macroeconomic factors:
    The growth of the Analgesics market in Haiti can also be attributed to several underlying macroeconomic factors. Firstly, the improving economic conditions in the country have led to an increase in disposable income among the population. This has allowed consumers to allocate a larger portion of their income towards healthcare and wellness products, including analgesics. Additionally, the expansion of the healthcare sector in Haiti, albeit gradual, has also contributed to the growth of the Analgesics market. The government's efforts to improve healthcare infrastructure and access to medical services have created a favorable environment for the market to thrive.In conclusion, the Analgesics market in Haiti is experiencing significant growth due to increasing customer preferences for pain relief medication, the shift towards OTC analgesics, local special circumstances such as limited access to healthcare services, and underlying macroeconomic factors such as improving economic conditions and healthcare infrastructure. This trend is expected to continue in the coming years as the demand for analgesics in Haiti continues to rise.

    Key Players

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Sales Channels

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Global Comparison

    Most recent update: Mar 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

    Health

    Access more Market Insights on Health topics with our featured report

    Analgesics: market data & analysis - BackgroundAnalgesics: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.